Home » Newsletters » BioWorld Science

BioWorld Science

March 15, 2022

View Archived Issues

2-Benzyllawsone shown to protect mice against polymicrobial sepsis

1st Bio Therapeutics identifies new ABL/LRRK2/LRRK2 mutant/RIPK2 inhibitors

Council of Scientific and Industrial Research patents nigericin derivatives

New psilocin prodrugs discovered at Compass Pathfinder

Novel antibacterials synthesized at the University of Jordan

Cybin IRL describes new 5-HT2 receptor agonists

LCFA-CoA inhibits NME1 and regulates cancer metastasis

TSC2 blockade activates mTORC1, improves photoreceptor survival and delays vision loss in RP

NuclixBio and PharmAbcine enter collaborative research agreement

Catamaran expands research collaboration with University of Minnesota on CAR-NK cell engineering

NexImmune enters melanoma research and evaluation collaboration with NYU Langone center

NSF grant supports Iaso's vaccine delivery research targeting infectious diseases and cancer

Gadeta advances GDT-201 toward IND filing for colorectal cancer

SIWA-318H shows efficacy in immune-competent humanized mouse xenograft model for pancreatic cancer

Mer inhibition as a promising new therapeutic strategy against septic ALI/ARDS

Activating activators is strategy against apoptosis defectors

FDA approves IND application for SM-17 for asthma

Elektrofi and Immunoprecise collaborate on self-administered formulation of PolyTope TATX-03

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...